CATALOGO DEI PRODOTTI DELLA RICERCA

LATTUADA, Emanuela
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 1.841
EU - Europa 1.750
AS - Asia 1.260
SA - Sud America 221
AF - Africa 39
Continente sconosciuto - Info sul continente non disponibili 2
OC - Oceania 2
Totale 5.115
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 1.788
RU - Federazione Russa 725
SG - Singapore 517
CN - Cina 378
GB - Regno Unito 305
BR - Brasile 184
IT - Italia 127
VN - Vietnam 123
SE - Svezia 115
DE - Germania 105
IE - Irlanda 96
FR - Francia 87
HK - Hong Kong 86
FI - Finlandia 74
KR - Corea 39
CA - Canada 31
UA - Ucraina 28
JP - Giappone 21
IN - India 20
CZ - Repubblica Ceca 17
MX - Messico 17
AR - Argentina 16
ZA - Sudafrica 16
TR - Turchia 14
PL - Polonia 13
NL - Olanda 12
BD - Bangladesh 11
BE - Belgio 10
NG - Nigeria 10
ES - Italia 8
AT - Austria 7
ID - Indonesia 7
IQ - Iraq 6
SA - Arabia Saudita 6
CL - Cile 5
LT - Lituania 5
PK - Pakistan 5
UZ - Uzbekistan 5
CO - Colombia 4
EG - Egitto 4
AE - Emirati Arabi Uniti 3
EC - Ecuador 3
GR - Grecia 3
MA - Marocco 3
PH - Filippine 3
PY - Paraguay 3
RO - Romania 3
AU - Australia 2
CY - Cipro 2
DO - Repubblica Dominicana 2
ET - Etiopia 2
GE - Georgia 2
HR - Croazia 2
IL - Israele 2
KZ - Kazakistan 2
NO - Norvegia 2
PE - Perù 2
SK - Slovacchia (Repubblica Slovacca) 2
TW - Taiwan 2
VE - Venezuela 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AM - Armenia 1
AZ - Azerbaigian 1
BA - Bosnia-Erzegovina 1
BG - Bulgaria 1
BO - Bolivia 1
CD - Congo 1
CH - Svizzera 1
DK - Danimarca 1
EU - Europa 1
GT - Guatemala 1
GY - Guiana 1
JM - Giamaica 1
KE - Kenya 1
KG - Kirghizistan 1
KW - Kuwait 1
LB - Libano 1
MN - Mongolia 1
PA - Panama 1
SN - Senegal 1
TN - Tunisia 1
Totale 5.115
Salva come PNG Salva come JPEG
Città #
Singapore 290
Moscow 252
Southend 246
Chandler 235
San Jose 167
Jacksonville 153
Ashburn 150
Woodbridge 127
Dublin 95
Dallas 90
Hong Kong 86
Beijing 74
Ann Arbor 70
New York 50
Verona 45
Los Angeles 42
The Dalles 42
Houston 41
Ho Chi Minh City 38
Lawrence 33
Princeton 33
Jinan 32
Wilmington 29
Munich 28
Shenyang 27
Helsinki 26
Hanoi 24
Nanjing 23
São Paulo 21
Tokyo 19
Santa Clara 16
Brno 15
Buffalo 15
Denver 15
Hebei 15
Orem 15
Frankfurt am Main 13
Redondo Beach 13
Toronto 13
Turku 13
Warsaw 13
Montreal 12
Atlanta 11
London 11
Nanchang 11
Ningbo 11
Brussels 10
San Francisco 10
Seoul 10
Tianjin 10
Abuja 9
Boardman 9
Changsha 9
Council Bluffs 9
Johannesburg 9
Amsterdam 8
Bologna 8
Haikou 8
Hangzhou 8
Phoenix 8
Redmond 8
Rio de Janeiro 8
Sindelfingen 8
Zhengzhou 8
Boston 7
Chennai 7
Jiaxing 7
Lanzhou 7
Milan 7
Clearwater 6
Guangzhou 6
Haiphong 6
Norwalk 6
Stockholm 6
Taizhou 6
Brooklyn 5
Dong Ket 5
Mexico City 5
Pignone 5
Seattle 5
Belo Horizonte 4
Bursa 4
Chicago 4
City of London 4
Madrid 4
Manchester 4
Monterrey 4
Mumbai 4
Paris 4
Poplar 4
Querétaro 4
Scandiano 4
Taiyuan 4
Tashkent 4
Thái Nguyên 4
Vicenza 4
Baghdad 3
Barnet 3
Buttapietra 3
Cairo 3
Totale 3.129
Salva come PNG Salva come JPEG
Nome #
Acute mediastinitis: a severe complication of transdermal therapy in a patient with ischaemic heart disease. A case report. 197
Pneumatocoele formation during Pneumocystis carinii pneumonia in a man with HIV-1 infection. 188
Dolutegravir Monotherapy in HIV-Infected Naive Patients With <100,000 Copies/mL HIV RNA Load 185
'High' antiretroviral deintensification strategy and cellular HIV DNA levels 185
Histoplasmosis in two human immunodeficiency virus-positive immigrants to Italy: clinical features and management in the highly active antiretroviral therapy era. 177
Dolutegravir monotherapy in HIV-1-suppressed patients: A feasible regimen in real life 177
Dolutegravir 50 mg thrice weekly plus atazanavir 400 mg daily in a long-term virologically suppressed HIV-infected patient 173
Raltegravir/nevirapine dual therapy at reduced doses as 'maintenance' treatment in virally suppressed HIV-infected patients 171
Is there a role for TNF-alpha in HIV1-associated lipodystrophy? 170
Immunovirological outcome and HIV-1 DNA decay in a small cohort of HIV-1-infected patients deintensificated from Abacavir/Lamivudine/Dolutegravir to Lamivudine plus Dolutegravir 168
Efavirenz dose reduction is associated with improved lipid profile in HIV-1 infected patients 168
No improvement of lipodystrophy syndrome in an HIV-infected patient. 165
Dual therapy with a combination of unboosted atazanavir and lamivudine as maintenance treatment in virologically suppressed HIV-1-infected patients 163
Discontinuation of non-nucleoside reverse transcriptase inhibitor-based antiretroviral therapy: clinical implications in patients on CD4 T-cell-guided treatment interruption. 161
Efficacy and safety of abacavir/lamivudine with raltegravir in treatment-experienced and treatment-naïve patients with HIV-1 infection: an observational, retrospective, multi-centre study 161
Short-Cycle Therapy (5 days on/2 days off) with a lamivudine-dolutegravir two-drug regimen in a cohort of virologically suppressed HIV-infected patients 161
Recreational substance use and tolerance of efavirenz in HIV-1 infected patients 158
Monoclonal gammopathy in HIV-Infected patients on stable antiretroviral therapy: disappearance or deep reduction? 157
Low plasmatic concentration of intensified antiretroviral therapy in a pregnant woman: a case report 156
Enanthema as the first clinical manifestation of abacavir hypersensitivity reaction: a case report. 154
Relationship between vertebral fractures, bone mineral density, and osteometabolic profile in HIV and Hepatitis B and C-infected patients treated with ART 150
Efficacy and safety of TAM-sparing antiretroviral regimens in naive HIV-positive patients 147
Dolutegravir monotherapy and body weight gain in antiretroviral naïve patients 139
Darunavir/ritonavir 600/100 mg once daily: it's time for larger non-inferiority randomized trials 138
Increase in visceral adipose tissue in a woman living with HIV after introduction of integrase strand transfer inhibitor 135
Efavirenz dose reduction in HIV-infected patients: a long-term follow-up 132
Raltegravir plus lamivudine as 'maintenance therapy' in suppressed HIV-1-infected patients in real-life settings 127
Efficacy of a reduced dose of darunavir/ritonavir in a cohort of antiretroviral-naive and -experienced HIV-infected patients: a medium-term follow-up 126
Raltegravir: is a 400 mg once-daily dose enough? 123
mIRTAZAPINE IN AN HIV-INFECTED PATIENT WITH PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY 120
Prevalence and clinical significance of Ureaplasma urealyticum and Mycoplasma hominis in the lower genital tract of HIV-1-infected women. 119
No influence of nevirapine on vitamin D deficiency in HIV-infected patients 104
Short-cycle therapy in {HIV}-infected adults: rilpivirine combination 4 days on/3 days off therapy 102
Prior Mycobacterium avium complex infection is linked to immunological nonresponsiveness in HIV-infected patients on highly active antiretroviral therapy 81
A precise characterisation of peptide binding stability to HLA-C alleles and correlation with the progression of HIV-1 infection and HIV-1 related neurocognitive impairment 23
A precise characterisation of peptide binding stability to HLA-C alleles and correlation with the progression of HIV-1 infection and HIV-1 related neurocognitive impairment 21
Totale 5.182
Salva come PNG Salva come JPEG
Categoria #
all - tutte 16.799
article - articoli 16.719
book - libri 0
conference - conferenze 80
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 33.598
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202148 0 0 0 0 0 0 0 0 0 13 24 11
2021/2022303 29 107 1 25 2 3 3 19 15 11 16 72
2022/2023620 36 85 50 94 62 154 0 39 77 2 10 11
2023/2024287 16 26 30 21 36 48 2 17 3 14 40 34
2024/2025673 37 41 15 97 38 13 37 18 112 46 62 157
2025/20262.252 146 112 119 425 657 161 177 88 215 152 0 0
Totale 5.182